NanoSignal Corp. CEO Comments on Current Developments and 2004 Outlook
18 February 2004, 09:00am ET
LAS VEGAS--(BUSINESS WIRE)--Feb. 18, 2004--NanoSignal Corp.'s (OTC BB:NNOS) newly appointed chief executive Scott A. Ervin took the occasion to summarize the following recent developments, and to extend a message of greeting to the company's shareholders and prospective investors.
First of all, the company's common shares now trade on three foreign exchanges in addition to the OTC Bulletin Board. NanoSignal is trading as NNOS.F on the Frankfurt (Germany) Exchange and NNOS.BE on the Berlin (Germany) Exchange; also as NNOS.DE on the European Xetra Exchange.
"I am most pleased to be on board and heading up the NanoSignal Corp. team and organization," stated Ervin. "We are now positioned to take this company to the next level, and the near-term developments are extremely promising, providing NanoSignal the opportunity to attract a much more significant following within the Wall Street community. The company should be able to gain additional exposure and support, based on fundamentals and real progress of its business plan, as we move forward."
As previously referenced in a public statement, Ervin has enjoyed a most distinguished career in real estate management, investment banking, and mergers-acquisitions with numerous Fortune 500 companies, including the First Boston Corp., Fisher Brothers and Rockefeller Center Inc. In November 2003, Ervin became president and CEO of MicroBio-Medical Systems Inc.
To summarize recent developments, NanoSignal was pleased to recently announce a definitive agreement with Dr. Jeffery Taft, a veteran of the early days of the company when it was known as MicroSignal and based in Pennsylvania, to join NanoSignal Corp. as a technical and scientific consultant. With Taft's addition to the team, NanoSignal Corp. is ready to pursue new applications of its technology -- most notably early detection of stroke. Cerebral blood flow and coronary artery blood flow are potential areas that show great promise using NanoSignal's proprietary technology.
Mentioned Last Change
NNOS 0.195 (Unchanged)
NanoSignal Corp. recently announced that it had entered into a consulting agreement with Al Noshirvani to develop sales and marketing of SLICES(TM). Noshirvani comes to NanoSignal with a wealth of sales and marketing experience, having been a sales professional in the medical equipment and health industries for more than 10 years. Noshirvani will help NanoSignal establish a national distribution network for SLICES(TM) and will implement a best business practices marketing program.
Incidentally, Noshirvani has scheduled a SLICES(TM) sales and marketing seminar for March 2004 in Las Vegas and further details will be announced when available.
NanoSignal announced recently that Felicia Browell has been hired to design a professional user manual for SLICES(TM). Browell will consult with Taft, Chris Puleo and Sherry Yavelak in accomplishing this project, and she will assist NanoSignal in creating comprehensive documentation that should make SLICES(TM) become recognized as the No. 1 leader in user-friendly software products for the MRI industry.
Ervin stated, "The company is actively in negotiations with multiple investment banking firms to meet its anticipated funding needs for national and international sales and marketing for the 2004-2005 period. Further details on this subject will be announced when warranted, and I would suggest that shareholders remain supportive and patient as the company transitions to what the management team believes will be bigger and better days ahead for NanoSignal. We appreciate the loyalty expressed by so many of the company's shareholders in the past year."
ill be baaaaaaaaaaaack.matt wants to play the delete 100 alias game......again.
